Tilray Brands, Inc.

TLRY

US88688T1007

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 01:30:00 18/07/2024 am IST			5-day change	1st Jan Change
1.9 ^USD	-1.55%		+3.83%	-17.39%

17/07	Tilray Brands Subsidiary Announces New Product Launch	MT
10/07	Get Ready to Elevate Your Cannabis Experience with Good Supply's Latest Signature Vape Innovations	CI

DOJA Cannabis Company Limited announced that it has received CAD 12.5 million in funding from Aphria Inc. and Koicha Partners LP

January 09, 2018

On January 9, 2018, DOJA Cannabis Company Limited (CNSX:DOJA) closed the transaction. The company issued 8,992,807 subscription receipts for gross proceeds of CAD 12,500,002.

Latest news about Tilray Brands, Inc.

Tilray Brands Subsidiary Announces New Product Launch	17/07	MT
Get Ready to Elevate Your Cannabis Experience with Good Supply's Latest Signature Vape Innovations	10/07	CI
Tilray Brief: Says Older Patients Represent a "Rapidly Growing Subset" for Therapeutic Medical Cannabis Use for Pain, Sleep, Quality of Life and Co-Medication	09/07	MT
Tilray Brief: Tilray Medical Announcing Scientific Study on Medical Cannabis for Patients Over Age 50	09/07	MT
Tilray Brands Launches Non-Alcoholic Brand Runner's High Brewing	27/06	MT
Tilray Brands, Inc. Announces Runner's High Brewing Company - Its New Brand of Premium Non-Alcoholic Brews	27/06	CI
Breckenridge Distillery Releases Award-Winning Collectors Art Series Collaboration with Abby Wren	25/06	CI
Tilray Medical Introduces Broken Coast Medical Cannabis Brand in Australia	20/06	MT
Tilray Brief: Tilray Medical Launching Broken Coast Medical Cannabis Brand in Australia	20/06	MT
Tilray Brands, Inc. Announces the Launch of 'Purple Churro,' by Redecan Cannabis	06/06	CI
Tilray Brands, Inc. Announces Good Supply Launches 'Twisted' All-In-One Vape	30/05	CI
Solei Brand Introduces New Cannabis-Infused ?Warming Deep Tissue Stick?	23/05	CI
TSX rises on commodity strength, CPI data in focus next week	18/05	RE
Toronto Stocks Edge Higher; Tilray Brands Shares Fall on $250 Million Share Sale Plans	17/05	DJ
Tilray Brands Plans Up To $250 Million 'At-The-Market' Offering -- Shares Fall	17/05	MT
Tilray Brands Launches At-The-Market Share Sale to Fund Acquisitions and Investments	17/05	MT
Tilray Brief: Announcing At-The-Market Program to Fund Strategic and Accretive Acquisitions and Accelerate Expansion Plan Upon U.S. Cannabis Rescheduling When Effective	17/05	MT
Social Buzz: Wallstreetbets Stocks Advance Premarket Friday; Reddit, AMC Entertainment to Open Higher	17/05	MT
Cannabis stocks rally after DOJ proposal to reclassify marijuana	17/05	RE
Pot stocks rise as US unveils proposal to ease restrictions on marijuana	17/05	RE
US Government Reclassifies Marijuana to Less-Restrictive Category	16/05	MT
Canopy Growth, Tilray Shares Rise After DOJ Proposes Marijuana Reclassification	16/05	DJ
Justice Department Set to Post Cannabis Reclassification Plans	16/05	MT
Stocks Uneven Pre-Bell as Wall Street Awaits Producer Price Report; Asia, Europe Churn	14/05	MT
Investors wary of US cannabis ETFs despite recent rally	07/05	RE

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company. The Company operates through four segments: Cannabis business, Distribution business, Beverage alcohol business and Wellness business. The Cannabis business segment is engaged in the production, distribution, sale, co-manufacturing, and advisory services of both medical and adult-use cannabis. The Distribution business segment is focused on the purchase and resale of pharmaceutical products to customers. The Beverage alcohol business segment is engaged in the production, marketing and sale of beverage and beverage alcohol products. The Wellness business segment includes hemp foods and hemp-based cannabidiol (CBD) consumer products. The Company offers a portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Bake Sale, XMG, Mollo, and others.

Sector

Pharmaceuticals

Calendar

29/07/2024 - Q4 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

US Consumer Confused About Pot Rules, Tilray CEO Says

October 18, 2023 at 12:08 am IST

More Strategies

Ratings for Tilray Brands, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

C-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

1.9 USD

Average target price

2.374 USD

Spread / Average Target

+24.92%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
TILRAY BRANDS, INC.	-17.39%	1.57B
ELI LILLY AND COMPANY	+55.35%	815B
NOVO NORDISK A/S	+32.14%	597B
JOHNSON & JOHNSON	-0.10%	377B
MERCK & CO., INC.	+15.47%	319B
ABBVIE INC.	+13.10%	310B
ASTRAZENECA PLC	+16.11%	247B
NOVARTIS AG	+14.03%	228B
AMGEN INC.	+16.54%	180B
PFIZER, INC.	+4.31%	170B

Other Pharmaceuticals

Tilray Brands, Inc.

Equities

TLRY

US88688T1007

Pharmaceuticals

DOJA Cannabis Company Limited announced that it has received CAD 12.5 million in funding from Aphria Inc. and Koicha Partners LP

Latest news about Tilray Brands, Inc.

Chart Tilray Brands, Inc.

Company Profile

Income Statement Evolution

Analysis / Opinion

Ratings for Tilray Brands, Inc.

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Pharmaceuticals